Stockreport

Crispr Therapeutics: Upcoming Catalysts May Validate The Bull Thesis And Force A Change In Plans [Seeking Alpha]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF The approval of CASGEVY, the first CRISPR-based medicine, for transfusion-dependent ß-thalassemia and sickle cell disease, signifies a significant milestone for the com [Read more]